Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | ||
| Net Income | -26,371 | -12,310 |
| Depreciation Amortization | 5,415 | 760 |
| Other Working Capital | 2,530 | 810 |
| Other Operating Activity | 5,486 | 2,690 |
| Operating Cash Flow | $-12,940 | $-8,050 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -37,597 | N/A |
| PPE Investments | -22,944 | -6,380 |
| Purchase Of Investment | -6,709 | N/A |
| Other Investing Activity | -1,500 | -1,810 |
| Investing Cash Flow | $-68,750 | $-8,190 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 25,615 | N/A |
| Common Stock Issued | 70,099 | N/A |
| Other Financing Activity | -24 | 19,670 |
| Financing Cash Flow | $95,690 | $19,670 |
| Beginning Cash Position | 9,413 | 5,980 |
| End Cash Position | 23,413 | 9,410 |
| Net Cash Flow | $14,000 | $3,420 |
| Free Cash Flow | ||
| Operating Cash Flow | -12,940 | -8,050 |
| Capital Expenditure | -22,944 | N/A |
| Free Cash Flow | -35,884 | -8,050 |